In today's Pre-Session Views: 

• Strategy| Market intelligence confirms Jirian contribution to PHDC value is minimal
• Macro| May 2025 inflation to hover around 15% on base effect
• CSAG vs ALCN| Post calling management of both firms, we continue to favor CSAG over ALCN
• RMDA| Strong FY25 ahead for RMDA, with growth momentum, molecule acquisition, and benefit from rate cuts
• TMGH conference call| Potential subsidiary listing on other markets could unlock value
• EGAL| Dividend powerhouse with structural tailwinds – Maintain positive view
• ARCC and Egypt Cement| Neutral but opportunities exist in smaller peers
• ECAP's 1Q25| Pressures mount as weak demand and cost concerns persist